DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/n4ghj5/2014_strategies) has announced the addition of the "2014 Strategies for the Cyclospora Diagnostic Testing Market" report to their offering.
The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Commercial/Private Labs
- Physician Offices
Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Cyclospora tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 191 pages and 7 tables</p
For more information visit http://www.researchandmarkets.com/research/n4ghj5/2014_strategies
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.